Overview


According to FutureWise analysis the market for bioinformatics in 2023 is US$ 14.36 billion, and is expected to reach US$ 39.87 billion by 2031 at a CAGR of 13.6%.

A scientific subdiscipline known as bioinformatics, which is connected to genetics and genomics, uses computer technology to gather, store, analyze, and share biological data and information, such as DNA and amino acid sequences or annotations about those sequences. Databases that organize and index this biological data are used by researchers and medical professionals to better understand health and disease and in some circumstances, as a component of patient care. Data analysis in the era of information and the Internet can be compared to the role of bioinformatics in biological research. Previously, accessing the information presented the biggest obstacle. That hurdle has been significantly lowered by developments in reading DNA sequences.

By using algorithms and software, bioinformatics is mostly used to derive knowledge from biological data. Bioinformatics is frequently used in the analysis of genomics, proteomics, 3D protein structure modelling, image analysis, drug creation, and many other fields. Precision and preventive medicine, which are primarily concerned with creating strategies to avoid, control, and treat terrifying infectious diseases, are two areas where bioinformatics is widely applied. Bioinformatics' primary goal is to improve understanding of biological processes.

FutureWise Market Research has published a report that provides an insightful analysis of bioinformatics market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the bioinformatics market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Thermo Fisher Scientific
  • Eurofins Scientific
  • Illumina
  • Perkinelmer, Inc.
  • Qiagen Bioinformatics
  • Agilent Technologies
  • Dnastar
  • Waters Corporation
  • Sophia Genetics
  • Partek
  • Biomax Informatics AG
  • Wuxi Nextcode
  • Beijing Genomics Institute (BGI)

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Bioinformatics Market:

In March 2022- Rio was introduced by ARUP as a bioinformatics pipeline and analytics platform for better, quick results from tests using next-generation sequencing.

In June 2022- LatchBio, a biotechnology research startup in California, developed an end-to-end bioinformatics platform for managing large amounts of biotech data in order to speed up scientific research.

Investigations and clinical trial techniques, such as those used in medication development, yield crucial data. High throughput screening and target identification are two additional essential applications that produce a lot of data and demand efficient analysis. The field of bioinformatics is constantly working to create new tools that can manage enormous and complex data volumes. These technologies accelerate the delivery of critical data to end users. This attracts businesses in the pharmaceutical and biotechnology sectors to utilize these technologies to handle their data, which boosts the bioinformatics market. The number of OMICS (genomics, proteomics, and metabolomics) research projects are constantly increasing, which contributes to the expansion of the bioinformatics applications used in such projects. Because of OMICS technology, there will likely be a surge in the demand for data analysis and storage. When it comes to gathering, processing, categorizing, and describing data in proteomics and genomics, the bioinformatics platform and methodology are crucial. Moreover, bioinformatics can be beneficial for forensic research, transcriptomics, next-generation sequencing (NGS), gene coding, and other disciplines. The field of bioinformatics is developing and becoming more and more recognized as an integrated tool. For instance, HPC (High-Performance Computing) systems are improving to suit the demands of bioinformatics by developing new hardware and software technologies. Techniques for manipulating bioinformatics data aid in the development of more precise prognoses and treatments for serious diseases. It is now possible to learn every element of cellular biology and follow the development of individual cells because to the advent of HPCs and technical advancements. This development brought on by bioinformatics tools is expected to present market participants with possibilities to generate revenue for this target market. However, Lack of qualified workers is one of the issues hindering the development of the bioinformatics industry. Due to the enormous amount of data that needs to be processed, the tools used in bioinformatics can currently only be used by highly skilled end users. Personnel who are qualified and skilled are required for this. The high operating expenses for the instruments are also a result of the complexity of the work done by bioinformatics software. The consequent need for training for those who do the activity limits the expansion of the bioinformatics market

By Products and Services

  • Knowledge Management Tools
    • Generalized Knowledge Management Tools
    • Specialized Knowledge Management Tools
  • Bioinformatics Platforms
    • Data Analysis Platforms
    • Structural And Functional Analysis Platforms
    • Other Bioinformatics Platforms
  • Bioinformatics Services
    • Data Analysis Services
    • Database Management Services
    • Other Bioinformatics Services

By Application

  • Genomics
  • Chemoinformatics And Drug Design
  • Proteomics
  • Transcriptomics
  • Metabolomics
  • Other Bioinformatics Applications

By Sector

  • Medical Biotechnology
    • Drug Discovery And Development
    • Clinical Diagnostics and Personalized Medicine
    • Reproductive Health
  • Academics
  • Animal Biotechnology
  • Agricultural Biotechnology
  • Environmental Biotechnology
  • Forensic Biotechnology
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022 due to a variety of variables, including an increase in the number of genetic engineering and nucleic acid research projects, an increase in funding for proteome and metagenomic techniques to discover new drugs and a growth in public awareness of the value of biological data. The main factors driving the bioinformatics market in the region are the rising advancements in molecular biology techniques, the high rate of acceptance of new healthcare technology, and the widespread use of genomic and proteomic research investigations.

The United States makes significant contributions to the study of drug development, genetics, and proteomics structure prediction. Funding for the development of various bioinformatics tools and devices that can handle a large amount of data being generated to understand the prognosis of diseases and treatment options has come from both public and private organizations, including the National Institutes of Health (NIH) and the Gates and Melinda Foundation. Since the United States generates a large number of genomic and proteomic data, there are significant investments made to support the creation of databases and the administration of biological data in the region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Bioinformatics Market By Products and Services, By Application, By Sector and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Bioinformatics Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Bioinformatics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Bioinformatics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Bioinformatics Market, By Product and Service Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Knowledge Management Tools
         1.1. Generalized Knowledge Management Tools
         1.2. Specialized Knowledge Management Tools
        2. Bioinformatics Platforms
         2.1. Data Analysis Platforms
         2.2. Structural And Functional Analysis Platforms
         2.3. Other Bioinformatics Platforms
        3. Bioinformatics Services
         3.1. Data Analysis Services
         3.2. Database Management Services
         3.3. Other Bioinformatics Services

  • 8.   Bioinformatics Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Genomics
        2. Chemoinformatics And Drug Design
        3. Proteomics
        4. Transcriptomics
        5. Metabolomics
        6. Other Bioinformatics Applications

  • 9.   Bioinformatics Market, By Sector Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Medical Biotechnology
         1.1. Drug Discovery And Development
         1.2. Clinical Diagnostics and Personalized Medicine
         1.3. Reproductive Health
        2. Academics
        3. Animal Biotechnology
        4. Agricultural Biotechnology
        5. Environmental Biotechnology
        6. Forensic Biotechnology
        7. Others

  • 10.   North America Bioinformatics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Bioinformatics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Bioinformatics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Bioinformatics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Thermo Fisher Scientific
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Eurofins Scientific
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Illumina
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Perkinelmer, Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Qiagen Bioinformatics
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Agilent Technologies
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Dnastar
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Waters Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Sophia Genetics
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Partek
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Biomax Informatics AG
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Wuxi Nextcode
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Beijing Genomics Institute (BGI)
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11